Literature DB >> 16533713

Oncology exploration: charting cancer medicinal chemistry space.

David G Lloyd1, Georgia Golfis, Andrew J S Knox, Darren Fayne, Mary J Meegan, Tudor I Oprea.   

Abstract

Approaches for the experimental determination of protein-ligand molecular interactions are reliant on the quality of the compounds being tested. The application of large, randomly designed combinatorial libraries has given way to the creation of more-focused 'drug-like' libraries. Prior to synthesis, we wish to screen the potential compounds to remove undesired chemical moieties and to be within a required range of physiochemical properties. We have used a principal-component analysis (PCA) computational approach to analyze the 3D descriptor space of active and non-active (hit-like) cancer medicinal chemistry compounds. We define hit-like those molecules passing the unmodified OpenEye FILTER program. Our analysis indicates that these compounds occupy quite different regions in space. Cancer-active compounds exist in a much greater volume of space than generic hit-like space and most of them fail the commonly applied filters for orally bioavailable drugs. This is of great significance when designing orally bioavailable cancer target drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16533713     DOI: 10.1016/S1359-6446(05)03688-3

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  9 in total

1.  Mappability of drug-like space: towards a polypharmacologically competent map of drug-relevant compounds.

Authors:  Pavel Sidorov; Helena Gaspar; Gilles Marcou; Alexandre Varnek; Dragos Horvath
Journal:  J Comput Aided Mol Des       Date:  2015-11-12       Impact factor: 3.686

2.  A cell-based molecular transport simulator for pharmacokinetic prediction and cheminformatic exploration.

Authors:  Xinyuan Zhang; Kerby Shedden; Gus R Rosania
Journal:  Mol Pharm       Date:  2006 Nov-Dec       Impact factor: 4.939

Review 3.  Computer-aided drug discovery and development (CADDD): in silico-chemico-biological approach.

Authors:  I M Kapetanovic
Journal:  Chem Biol Interact       Date:  2006-12-16       Impact factor: 5.192

4.  Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.

Authors:  Mona A Mohamed; Margaret R Lentz; Vallent Lee; Elkan F Halpern; Ned Sacktor; Ola Selnes; Peter B Barker; Martin G Pomper
Journal:  Radiology       Date:  2010-02       Impact factor: 11.105

5.  Factor analysis reveals differences in brain metabolism in macaques with SIV/AIDS and those with SIV-induced encephalitis.

Authors:  Margaret R Lentz; Vallent Lee; Susan V Westmoreland; Eva-Maria Ratai; Elkan F Halpern; R Gilberto González
Journal:  NMR Biomed       Date:  2008-10       Impact factor: 4.044

Review 6.  Rational methods for the selection of diverse screening compounds.

Authors:  David J Huggins; Ashok R Venkitaraman; David R Spring
Journal:  ACS Chem Biol       Date:  2011-02-15       Impact factor: 5.100

7.  Exploring DNA topoisomerase I ligand space in search of novel anticancer agents.

Authors:  Malgorzata N Drwal; Keli Agama; Laurence P G Wakelin; Yves Pommier; Renate Griffith
Journal:  PLoS One       Date:  2011-09-22       Impact factor: 3.240

8.  Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters.

Authors:  Walid Fayad; Mårten Fryknäs; Slavica Brnjic; Maria Hägg Olofsson; Rolf Larsson; Stig Linder
Journal:  PLoS One       Date:  2009-10-02       Impact factor: 3.240

Review 9.  In silico pharmacology for drug discovery: applications to targets and beyond.

Authors:  S Ekins; J Mestres; B Testa
Journal:  Br J Pharmacol       Date:  2007-06-04       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.